{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:11:20Z","timestamp":1792635080664,"version":"4.5.0"},"reference-count":40,"publisher":"Archives of Endocrinology and Metabolism","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,16]]},"DOI":"10.20945\/2359-3997000000554","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T07:12:02Z","timestamp":1668669122000},"page":"651-657","source":"Crossref","is-referenced-by-count":5,"title":["Treatment options in hypoparathyroidism"],"prefix":"10.20945","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-4410","authenticated-orcid":false,"given":"Eliane Naomi","family":"Sakane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-601X","authenticated-orcid":false,"given":"Maria Carolina Camargo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5999-093X","authenticated-orcid":false,"given":"Gabriela Mazzarolo Marcondes","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-4245","authenticated-orcid":false,"given":"Sergio Setsuo","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"6","key":"key20221117071146_B1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","unstructured":"Bilezikian JP. Hypoparathyroidism. J Clin Endocrinol Metab. 2020;105(6):1722-36.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20221117071146_B2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and Diagnosis of Hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, J\u00fcppner H, Lakatos PL, Levine MA, et al. Epidemiology and Diagnosis of Hypoparathyroidism. J Clin Endocrinol Metab. 2016;101(6):2284-99.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key20221117071146_B3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28(11):2277-85.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"key20221117071146_B4","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study","volume":"30","author":"Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J Bone Miner Res. 2015;30(9):1738-44.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"key20221117071146_B5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of Hypoparathyroidism: Summary Statement and Guidelines","volume":"101","author":"Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, et al. Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab. 2016;101(6):2273-83.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20221117071146_B6","volume-title":"Guyton and Hall Textbook of Medical Physiology","author":"Hall","year":"2020","unstructured":"Hall JE, Guyton AC. Guyton and Hall Textbook of Medical Physiology. 14th ed. London, England: W B Saunders; 2020. Chapter 80.","edition":"14th ed."},{"key":"key20221117071146_B7","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","unstructured":"Gafni RI, Collins MT. Hypoparathyroidism. N Engl J Med. 2019;380:1738-47.","journal-title":"N Engl J Med"},{"issue":"3","key":"key20221117071146_B8","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-18-0609","article-title":"Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus","volume":"180","author":"Khan","year":"2019","unstructured":"Khan AA, Koch CA, Uum SV, Baillargeon JP, Bollerslev J, Brandi ML, et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019;180(3):P1-22.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key20221117071146_B9","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Guideline: Treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, Biesen WV, et al. European Society of Endocrinology Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1-20.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"key20221117071146_B10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1515\/cclm-2013-0315","article-title":"Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review","volume":"51","author":"Hanon","year":"2013","unstructured":"Hanon EA, Sturgeon CM, Lamb EJ. Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review. Clin Chem Lab Med. 2013;51(10):1925-41.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"key20221117071146_B11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.20945\/2359-3997000000015","article-title":"Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism","volume":"62","author":"Maeda","year":"2018","unstructured":"Maeda SS, Moreira CA, Boraba VZC, Bandeira F, Farias MLF, Borges JLC, et al. Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab. 2018;62(1):106-24.","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"key20221117071146_B12","first-page":"171","article-title":"Postsurgical Hypoparathyroidism: A Systematic Review","volume":"30","author":"Kakava","year":"2016","unstructured":"Kakava K, Tournis S, Papadakis G, Karelas I, Stampouloglou P, Kassi E, et al. Postsurgical Hypoparathyroidism: A Systematic Review. In Vivo. 2016:30(3):171-9.","journal-title":"In Vivo"},{"issue":"10","key":"key20221117071146_B13","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1530\/EC-20-0366","article-title":"Challenges in the management of chronic hypoparathyroidism","volume":"9","author":"Zavatta","year":"2020","unstructured":"Zavatta G, Clarke BL. Challenges in the management of chronic hypoparathyroidism. Endocr Connect. 2020;9(10):R229-40.","journal-title":"Endocr Connect"},{"issue":"8","key":"key20221117071146_B14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0043-106441","article-title":"Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update","volume":"125","author":"Iglesias","year":"2017","unstructured":"Iglesias P, D\u00edez JJ. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update. Exp Clin Endocrinol Diabetes. 2017;125(8):497-505.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"key20221117071146_B15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12020-020-02324-2","article-title":"Diagnosis and management of hypocalcemia","volume":"69","author":"Pepe","year":"2020","unstructured":"Pepe J, Colangelo L, Biamonte F, Sonato C, Danese VC, Cecchetti V, et al. Diagnosis and management of hypocalcemia. Endocrine. 2020;69(3):485-95.","journal-title":"Endocrine"},{"issue":"4","key":"key20221117071146_B16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ecl.2018.07.009","article-title":"Hypoparathyroidism and the Kidney","volume":"47","author":"Peacock","year":"2018","unstructured":"Peacock M. Hypoparathyroidism and the Kidney. Endocrinol Metab Clin North Am. 2018;47(4):839-53.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"key20221117071146_B17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ecl.2018.07.012","article-title":"Conventional Treatment of Hypoparathyroidism","volume":"47","author":"Babey","year":"2018","unstructured":"Babey M, Brandi ML, Shoback D. Conventional Treatment of Hypoparathyroidism. Endocrinol Metab Clin North Am. 2018;47(4):889-900.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"key20221117071146_B18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/0004-2730000003388","article-title":"Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D","volume":"58","author":"Maeda","year":"2014","unstructured":"Maeda SS, Borba VZ, Camargo MB, Silva DM, Borges JL, Bandeira F, et al.; Brazilian Society of Endocrinology and Metabology (SBEM). Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arq Bras Endocrinol Metabol. 2014;58(5):411-33.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"7","key":"key20221117071146_B19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20221117071146_B20","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"Bilezikian","year":"2017","unstructured":"Bilezikian JP. Primer on the metabolic bone diseases and disorders of mineral metabolism. Hoboken: Wiley-Blackwell; 2017. Chapter 30."},{"key":"key20221117071146_B21","article-title":"Management of Hypoparathyroidism: Present and Future","volume":"3","author":"Bilezikian","year":"2016","unstructured":"Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, et al. Management of Hypoparathyroidism: Present and Future. JCEM. 2016;3:jc20153910.","journal-title":"JCEM"},{"issue":"10","key":"key20221117071146_B22","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. JBMR. 2011;26(10):2317-37.","journal-title":"JBMR"},{"issue":"9","key":"key20221117071146_B23","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","unstructured":"Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, et al. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. JCEM. 2003;88(9):4214-20.","journal-title":"JCEM"},{"issue":"8","key":"key20221117071146_B24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","unstructured":"Winer KK, Yanovski JA, Cutler GB Jr. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA. 1996;276(8):631-6.","journal-title":"JAMA"},{"issue":"10","key":"key20221117071146_B25","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB Jr. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. JCEM. 1998;83(10):3480-6.","journal-title":"JCEM"},{"issue":"9","key":"key20221117071146_B26","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","unstructured":"Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. JCEM. 2008;93(9):3389-95.","journal-title":"JCEM"},{"issue":"6","key":"key20221117071146_B27","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","unstructured":"Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. JCEM. 2010;95(6):2680-8.","journal-title":"JCEM"},{"issue":"1","key":"key20221117071146_B28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12020-020-02577-x","article-title":"Chronic hypoparathyroidism and treatment with teriparatide","volume":"72","author":"Marcucci","year":"2021","unstructured":"Marcucci G, Masi L, Cianferotti L, Giusti F, Fossi C, Parri S, et al. Chronic hypoparathyroidism and treatment with teriparatide. Endocrine. 2021;72(1):249-59.","journal-title":"Endocrine"},{"issue":"8","key":"key20221117071146_B29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","unstructured":"Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, et al. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. JBMR. 2012;27(8):1811-20.","journal-title":"JBMR"},{"key":"key20221117071146_B30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2018.09.018","article-title":"Advances in the treatment of hypoparathyroidism with PTH 1-34","volume":"120","author":"Winer","year":"2019","unstructured":"Winer KK. Advances in the treatment of hypoparathyroidism with PTH 1-34. Bone. 2019;120:535-41.","journal-title":"Bone"},{"issue":"5","key":"key20221117071146_B31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone(1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study","volume":"36","author":"Clarke","year":"2014","unstructured":"Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone(1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clin Ther. 2014;36(5):722-36.","journal-title":"Clin Ther"},{"issue":"11","key":"key20221117071146_B32","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","unstructured":"Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP. Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int. 2010;21(11):1927-34.","journal-title":"Osteoporos Int"},{"issue":"10","key":"key20221117071146_B33","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L; Hypoparathyroid Study Group. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. JBMR. 2011;26(10):2358-70.","journal-title":"JBMR"},{"issue":"11","key":"key20221117071146_B34","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1210\/jc.2019-00893","article-title":"Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety","volume":"104","author":"Tay","year":"2019","unstructured":"Tay YD, Tabacco G, Cusano NE, Williams J, Omeragic B, Majeed R, et al. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety. J Clin Endocrinol Metab. 2019;104(11):5601-10.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20221117071146_B35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a doubleblind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","unstructured":"Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, et al. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a doubleblind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013;1(4):275-83.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key20221117071146_B36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.beem.2014.09.001","article-title":"Parathyroid hormone therapy for hypoparathyroidism","volume":"29","author":"Cusano","year":"2015","unstructured":"Cusano NE, Rubin MR, Bilezikian JP. Parathyroid hormone therapy for hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2015;29(1):47-55.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"key20221117071146_B37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/jcm10071378","article-title":"Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management","volume":"10","author":"Ali","year":"2021","unstructured":"Ali DS, Dandurand K, Khan AA. Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management. J Clin Med. 2021;10(7):1378.","journal-title":"J Clin Med"},{"issue":"1","key":"key20221117071146_B38","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","article-title":"PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism","volume":"107","author":"Khan","year":"2022","unstructured":"Khan AA, Rejnmark L, Rubin M, Schwarz P, Vokes T, Clarke B, et al. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2022;107(1):e372-85.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20221117071146_B39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.3747","article-title":"Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635)","volume":"34","author":"Roberts","year":"2019","unstructured":"Roberts MS, Gafni RI, Brillante B, Guthrie LC, Streit J, Gash D, et al. Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635). J Bone Miner Res. 2019;34(9):1609-18.","journal-title":"J Bone Miner Res"},{"issue":"19","key":"key20221117071146_B40","doi-asserted-by":"crossref","first-page":"10272","DOI":"10.3390\/ijms221910272","article-title":"Hypoparathyroidism: State of the Art on Cell and Tissue Therapies","volume":"22","author":"Miglietta","year":"2021","unstructured":"Miglietta F, Palmini G, Giusti F, Donati S, Aurilia C, Iantomasi T, et al. Hypoparathyroidism: State of the Art on Cell and Tissue Therapies. Int J Mol Sci. 2021;22(19):10272.","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T07:12:31Z","timestamp":1668669151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/treatment-options-in-hypoparathyroidism\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,16]]}},"alternative-id":["10.20945\/2359-3997000000554"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000554","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}